Health plans have more incentives than ever to foster competition, but efforts in the past have failed
The internationally known health care economist says we have been heading in the right direction all along — we just have to tackle problems in the right order
Employees won’t be abandoned by their companies, whose contributions will continue to rise — somewhat
Which of three drugs is best for a given patient? The answer remains clouded by clinical uncertainty — and the sun isn’t going to break through soon.
UM for outpatient discretionary echocardiography appeared to reduce testing rates significantly
Andrea DeVries, PhD ; Gosia Sylwestrzak, MA ; Abiy Agiro, PhD ; Thomas Power, MD
There have been no novel medications for decades, and exisiting therapies don’t have enough of an impact on morbidity and mortality rates
Aetna hopes that an experiment with its employees turns into a product that it can put on the market next year
Physicians will be able to order the correct therapy in as little as two hours after taking a sample for testing
News & Commentary
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweißen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.